MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2019 International Congress

    Opicapone and levodopa-carbidopa intestinal gel infusion: a cost saving analysis in the United Kingdom

    V. Leta, D. van Wamelen, A. Sauerbier, S. Jones, A. Podlewska, D. Trivedi, M. Parry, P. Odin, A. Storch, Z. Pirtošek, A. Antonini, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate whether the use of Opicapone as an add-on therapy to levodopa-carbidopa intestinal gel (LCIG) infusion in advanced Parkinson’s disease (PD) reduces the…
  • 2019 International Congress

    Effect of gastrointestinal surgery on the pharmacokinetics of levodopa in Parkinson’s disease

    N. Miyaue, M. Nomoto, H. Yabe, Y. Yamanishi, S. Tada, R. Ando, M. Kubo, M. Nagai (Ehime, Japan)

    Objective: The aim of this study is to evaluate the pharmacokinetics of levodopa in patients with Parkinson’s disease (PD) who underwent gastrointestinal surgery. Background: Levodopa…
  • 2019 International Congress

    Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease

    M. Fabbri, P. Chatkaew, C. Artusi, A. Romagnolo, M. Rizzone, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To investigate the long-term effect of levodopa-carbidopa intestinal gel (LCIG) on axial signs in Parkinson's disease (PD) patients and the related prognostic factors. Background:…
  • 2019 International Congress

    Clinical features of constipation in patients with Parkinson’s disease: a cross-sectional study in China

    LP. Zhu, XT. Zhou, Z. Zhou, LJ. Fang, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: This study was designed to explore the clinical features of constipation, and investigate the risk factors of constipation in Chinese PD patients. Background: Constipation…
  • 2019 International Congress

    Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

    S. Joza, F. Ba (Edmonton, AB, Canada)

    Objective: To present a case report of Levocarb-induced diplopia in idiopathic Parkinson’s disease. Background: Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by a…
  • 2018 International Congress

    Does the effect of continuous levodopa infusion treatment for Parkinson’s disease regress as the day progresses?

    I. Thomas, M. Memedi, D. Nyholm, J. Westin (Borlange, Sweden)

    Objective: The goal of this project is to examine if there is evidence to suggest that there is a difference in response to levodopa during…
  • 2018 International Congress

    Epidemiological and clinical profile of Parkinson’s disease in Douala

    J. Doumbe, H. Bohongwe, Y. Mapoure, C. Kuate (Douala, Cameroon)

    Objective: The aim of our study was to determine the hospital prevalence and describe the epidemiological and clinical profile of Parkinson’s disease in Douala Background:…
  • 2018 International Congress

    Impact of Age on Levodopa dosage regimes in Idiopathic Parkinson’s Disease

    L. Scourfield, S. Sultana, C. Thomas, B. Mohamed (Cardiff, United Kingdom)

    Objective: To assess the influence of patient age on prescribed dosage and subsequent dose escalation regimes of levodopa therapy in a cohort of people with…
  • 2018 International Congress

    A case of levodopa responsive rapid onset dystonia-parkinsonism

    Y. Fernandez, S. Frucht (New York, NY, USA)

    Objective: We describe and demonstrate by video a young man with rapid onset dystonia parkinsonism who has a robust response to levodopa. Background: Rapid onset…
  • 2018 International Congress

    Effect of medication on lexical tone production in Cantonese patients with Parkinson’s Disease

    A. Chan, S. Chen, J. Shao, C.C. Zhang, I. Lam, S. Pang, V. Ngan, J. Tam, W.C. Yang, J. Ngan, S. Pinto (Hong Kong)

    Objective: To examine how dysarthria resulting from Parkinson’s Disease (PD) affects lexical tone production in Cantonese-speaking patients and to evaluate the effects of medication Background:…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 62
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley